OnMyWay Posted August 16, 2021 Author Posted August 16, 2021 29 minutes ago, RBM said: Before you test BP try relaxing 5 minutes, deep breathing, slowly exhaling breath. Ensure arm at chest height. Recommended is test twice, place more emphasize on second test. Some docs actually say forget first test....Kinda weird as they test only once in my experience. Yes, this is what I do. Sometimes, if the first reading is high, I even test 3 times. 95% of the time the reading goes lower with each test. And by test, I mean the using the Omron 3X setting that does three tests and averages the results. I try to meditate while taking it and close my eyes. Before, I would look at the digital reading during the test. As described earlier, the testing they did at the vaccination site was totally the opposite of this. 2 Link to comment Share on other sites More sharing options...
Jollygoodfellow Posted August 16, 2021 Posted August 16, 2021 On 8/15/2021 at 8:32 PM, jimeve said: I'm getting over a fever that I had, lasted 5 days, don't really know what the cause was, gave me a rash on my back. I'v had sinovac 2x, so can't be covid-19. It can be covid. Vaccination does not prevent it. Just lessons the effect. Most common symptoms: fever dry cough tiredness Less common symptoms: aches and pains sore throat diarrhoea conjunctivitis headache loss of taste or smell a rash on skin, or discolouration of fingers or toes Serious symptoms: difficulty breathing or shortness of breath chest pain or pressure loss of speech or movement 2 Link to comment Share on other sites More sharing options...
Dave Hounddriver Posted August 16, 2021 Posted August 16, 2021 51 minutes ago, Jollygoodfellow said: It can be covid. Vaccination does not prevent it. Just lessons the effect. It was recently noted on "another forum" that one of their 80+ year old members was fully vaccinated and still passed away from complications of covid. I am sure vaccines help, but they are not perfect. 2 Link to comment Share on other sites More sharing options...
Jollygoodfellow Posted August 16, 2021 Posted August 16, 2021 2 hours ago, Dave Hounddriver said: It was recently noted on "another forum" that one of their 80+ year old members was fully vaccinated and still passed away from complications of covid. I am sure vaccines help, but they are not perfect. Usually it's because of other reasons complicating the matter such as diabetes etc so probably at 80+ there was more to it. 4 Link to comment Share on other sites More sharing options...
BrettGC Posted August 16, 2021 Posted August 16, 2021 (edited) 6 hours ago, Jollygoodfellow said: It can be covid. Vaccination does not prevent it. Just lessons the effect. Most common symptoms: fever dry cough tiredness Less common symptoms: aches and pains sore throat diarrhoea conjunctivitis headache loss of taste or smell a rash on skin, or discolouration of fingers or toes Serious symptoms: difficulty breathing or shortness of breath chest pain or pressure loss of speech or movement It comes down to the efficacy figure for the different vaccines. Say you have the Pfizer vaccine with its 90-95% efficacy, that means 5-10% of the vaccinated group can still catch covid and if they do, their symptoms are generally reduced due to the antibodies already being present in the system. It doesn't mean you have 90-95% less severe symptoms if you are vaccinated. This is the case for any vaccine, even the ones that have been around for years like the MMR vaccine (measles, mumps, rubella) for example, which have an efficacy of 93, 97 and 88% respectively. The high efficacy figure is the reason many diseases have been wiped out in countries that routinely vaccine at high numbers for any given pathogen, even if it takes years. Efficacy is a measure of prevention, not mitigation. In the case of covid, the efficacy figure is still evolving for the different vaccines. WHO has an interesting article on efficacy: https://www.who.int/news-room/feature-stories/detail/vaccine-efficacy-effectiveness-and-protection Quote Vaccine efficacy, effectiveness and protection 14 July 2021 العربية 中文 Français Русский Español Português This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series. COVID-19 vaccines have proven to be safe, effective and life-saving. Like all vaccines, they do not fully protect everyone who is vaccinated, and we do not yet know how well they can prevent people from transmitting the virus to others. So as well as getting vaccinated, we must also continue with other measures to fight the pandemic. Vaccine efficacy and effectiveness All COVID-19 vaccines approved by WHO for emergency use listing have been through randomized clinical trials to test their quality, safety and efficacy. To be approved, vaccines are required to have a high efficacy rate of 50% or above. After approval, they continue to be monitored for ongoing safety and effectiveness. But what is the difference between efficacy and effectiveness? A vaccine’s efficacy is measured in a controlled clinical trial and is based on how many people who got vaccinated developed the ‘outcome of interest’ (usually disease) compared with how many people who got the placebo (dummy vaccine) developed the same outcome. Once the study is complete, the numbers of sick people in each group are compared, in order to calculate the relative risk of getting sick depending on whether or not the subjects received the vaccine. From this we get the efficacy – a measure of how much the vaccine lowered the risk of getting sick. If a vaccine has high efficacy, a lot fewer people in the group who received the vaccine got sick than the people in the group who received the placebo. So, for example, let’s imagine a vaccine with a proven efficacy of 80%. This means that – out of the people in the clinical trial – those who received the vaccine were at a 80% lower risk of developing disease than the group who received the placebo. This is calculated by comparing the number of cases of disease in the vaccinated group versus the placebo group. An efficacy of 80% does not mean that 20% of the vaccinated group will become ill. Vaccine effectiveness is a measure of how well vaccines work in the real world. Clinical trials include a wide range of people – a broad age range, both sexes, different ethnicities and those with known medical conditions – but they cannot be a perfect representation of the whole population. The efficacy seen in clinical trials applies to specific outcomes in a clinical trial . Effectiveness is measured by observing how well the vaccines work to protect communities as a whole. Effectiveness in the real world can differ from the efficacy measured in a trial, because we can’t predict exactly how effective vaccination will be for a much bigger and more variable population getting vaccinated in more real life conditions. Vaccine protection and timing Vaccines offer strong protection, but that protection takes time to build. People must take all the required doses of a vaccine to build full immunity. For two-dose vaccines, vaccines only give partial protection after the first dose, and the second dose increases that protection. It takes time before protection reaches its maximum level a few weeks after the second dose. For a one-dose vaccine, people will have built maximum immunity against COVID-19 a few weeks after getting vaccinated. Vaccine protection and infection Vaccines can stop most people from getting sick with COVID-19, but not everyone. Even after someone takes all of the recommended doses and waits a few weeks for immunity to build up, there is still a chance that they can get infected. Vaccines do not provide full (100%) protection, so ‘breakthrough infections’ – where people get the virus, despite having been fully vaccinated – will occur. If vaccinated people do get sick, they are likely to have milder symptoms, in general 'It is very rare for someone vaccinated to experience severe illness or die. Vaccine protection and transmission COVID-19 vaccines are crucial tools in the pandemic response and protect against severe disease and death. Vaccines provide at least some protection from infection and transmission, but not as much as the protection they provide against serious illness and death. More evidence is needed to determine exactly how well they stop infection and transmission. After being vaccinated, individuals should continue taking simple precautions, such as physical distancing, wearing a mask, keeping rooms well ventilated, avoiding crowds, cleaning hands, and coughing into a bent elbow or tissue. Get tested if you are sick, even if you’ve been vaccinated. Check local advice where you live and work. Do it all! Vaccine protection and variants When cases increase and transmission accelerates, it’s more likely that new dangerous and more transmissible variants emerge, which can spread more easily or cause more severe illness. Based on what we know so far, vaccines are proving effective against existing variants, especially at preventing severe disease, hospitalization and death. However, some variants are having a slight impact on the ability of vaccines to guard against mild disease and infection. Vaccines are likely staying effective against variants because of the broad immune response they cause, which means that virus changes or mutations are unlikely to make vaccines completely ineffective. WHO continues to constantly review the evidence and will update its guidance as we find out more. For the latest updates on what we know about the COVID-19 variants, read our latest weekly epidemiological updates and our explainer on ‘the effects of virus variants on COVID-19 vaccines’. One of the best ways of guarding against new variants is to continue applying tried-and-tested public health measures and rolling out vaccines. All COVID-19 vaccines approved for emergency use listing by WHO have been thoroughly tested and proven to provide a high degree of protection against serious illness and death. As stronger virus variants emerge, it’s important to take your vaccine when it’s your turn. Edited August 17, 2021 by BrettGC 4 Link to comment Share on other sites More sharing options...
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series. COVID-19 vaccines have proven to be safe, effective and life-saving. Like all vaccines, they do not fully protect everyone who is vaccinated, and we do not yet know how well they can prevent people from transmitting the virus to others. So as well as getting vaccinated, we must also continue with other measures to fight the pandemic. Vaccine efficacy and effectiveness All COVID-19 vaccines approved by WHO for emergency use listing have been through randomized clinical trials to test their quality, safety and efficacy. To be approved, vaccines are required to have a high efficacy rate of 50% or above. After approval, they continue to be monitored for ongoing safety and effectiveness. But what is the difference between efficacy and effectiveness? A vaccine’s efficacy is measured in a controlled clinical trial and is based on how many people who got vaccinated developed the ‘outcome of interest’ (usually disease) compared with how many people who got the placebo (dummy vaccine) developed the same outcome. Once the study is complete, the numbers of sick people in each group are compared, in order to calculate the relative risk of getting sick depending on whether or not the subjects received the vaccine. From this we get the efficacy – a measure of how much the vaccine lowered the risk of getting sick. If a vaccine has high efficacy, a lot fewer people in the group who received the vaccine got sick than the people in the group who received the placebo. So, for example, let’s imagine a vaccine with a proven efficacy of 80%. This means that – out of the people in the clinical trial – those who received the vaccine were at a 80% lower risk of developing disease than the group who received the placebo. This is calculated by comparing the number of cases of disease in the vaccinated group versus the placebo group. An efficacy of 80% does not mean that 20% of the vaccinated group will become ill. Vaccine effectiveness is a measure of how well vaccines work in the real world. Clinical trials include a wide range of people – a broad age range, both sexes, different ethnicities and those with known medical conditions – but they cannot be a perfect representation of the whole population. The efficacy seen in clinical trials applies to specific outcomes in a clinical trial . Effectiveness is measured by observing how well the vaccines work to protect communities as a whole. Effectiveness in the real world can differ from the efficacy measured in a trial, because we can’t predict exactly how effective vaccination will be for a much bigger and more variable population getting vaccinated in more real life conditions. Vaccine protection and timing Vaccines offer strong protection, but that protection takes time to build. People must take all the required doses of a vaccine to build full immunity. For two-dose vaccines, vaccines only give partial protection after the first dose, and the second dose increases that protection. It takes time before protection reaches its maximum level a few weeks after the second dose. For a one-dose vaccine, people will have built maximum immunity against COVID-19 a few weeks after getting vaccinated. Vaccine protection and infection Vaccines can stop most people from getting sick with COVID-19, but not everyone. Even after someone takes all of the recommended doses and waits a few weeks for immunity to build up, there is still a chance that they can get infected. Vaccines do not provide full (100%) protection, so ‘breakthrough infections’ – where people get the virus, despite having been fully vaccinated – will occur. If vaccinated people do get sick, they are likely to have milder symptoms, in general 'It is very rare for someone vaccinated to experience severe illness or die. Vaccine protection and transmission COVID-19 vaccines are crucial tools in the pandemic response and protect against severe disease and death. Vaccines provide at least some protection from infection and transmission, but not as much as the protection they provide against serious illness and death. More evidence is needed to determine exactly how well they stop infection and transmission. After being vaccinated, individuals should continue taking simple precautions, such as physical distancing, wearing a mask, keeping rooms well ventilated, avoiding crowds, cleaning hands, and coughing into a bent elbow or tissue. Get tested if you are sick, even if you’ve been vaccinated. Check local advice where you live and work. Do it all! Vaccine protection and variants When cases increase and transmission accelerates, it’s more likely that new dangerous and more transmissible variants emerge, which can spread more easily or cause more severe illness. Based on what we know so far, vaccines are proving effective against existing variants, especially at preventing severe disease, hospitalization and death. However, some variants are having a slight impact on the ability of vaccines to guard against mild disease and infection. Vaccines are likely staying effective against variants because of the broad immune response they cause, which means that virus changes or mutations are unlikely to make vaccines completely ineffective. WHO continues to constantly review the evidence and will update its guidance as we find out more. For the latest updates on what we know about the COVID-19 variants, read our latest weekly epidemiological updates and our explainer on ‘the effects of virus variants on COVID-19 vaccines’. One of the best ways of guarding against new variants is to continue applying tried-and-tested public health measures and rolling out vaccines. All COVID-19 vaccines approved for emergency use listing by WHO have been thoroughly tested and proven to provide a high degree of protection against serious illness and death. As stronger virus variants emerge, it’s important to take your vaccine when it’s your turn.
jimeve Posted August 17, 2021 Posted August 17, 2021 7 hours ago, Jollygoodfellow said: Most common symptoms: fever dry cough tiredness No dry cough or any other cough. 1 Link to comment Share on other sites More sharing options...
Guest Posted August 17, 2021 Posted August 17, 2021 Got my second jab of AZ on the 9th. One hour and 15 minutes. No side effects except a very rare bruise at the injection site. Well, a second side-effect that was not from the shot but from the process: sore thighs from hopping up and down while playing musical chairs in the several lines. 1 2 Link to comment Share on other sites More sharing options...
OnMyWay Posted August 17, 2021 Author Posted August 17, 2021 5 hours ago, JDDavao said: Got my second jab of AZ on the 9th. One hour and 15 minutes. No side effects except a very rare bruise at the injection site. That is a long time to hold the needle steady. No wonder you had a bruise. 4 Link to comment Share on other sites More sharing options...
Jollygoodfellow Posted August 17, 2021 Posted August 17, 2021 8 hours ago, jimeve said: No dry cough or any other cough. I think you said a rash which is on the list. Everyone will react different. Link to comment Share on other sites More sharing options...
jimeve Posted August 18, 2021 Posted August 18, 2021 15 hours ago, Jollygoodfellow said: I think you said a rash which is on the list. Everyone will react different. Yeah, I had a rash on my back and arms. I isolated for 8 days just in case, feeling fine now got my appetite back. When I do got out it will stay in the car and double bag. I very much doubt it was covid-19. Symptoms didn't add up. If anything it was anxiety, stress. 1 Link to comment Share on other sites More sharing options...
Recommended Posts